Showing results (21-30 of 161) with videos related to
Sort By:
Pageof 17
Wellcome Open Research|October 23, 2018
Daytime variation in hepatitis C virus replication kinetics following liver transplantXiaodong Zhuang, Alvina G Lai, Jane A McKeating, et al.Oxford Open Immunology|October 13, 2020
Cholesterol-modifying drugs in COVID-19Nathalie M Schmidt, Peter A C Wing, Jane A McKeating, et al.Journal of Virology|October 20, 2006
Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type ISharookh B Kapadia, Heidi Barth, Thomas Baumert, et al.Scientific Reports|September 8, 2018
Metallo supramolecular cylinders inhibit HIV-1 TAR-TAT complex formation and viral replication in celluloLucia Cardo, Isabel Nawroth, Peter J Cail, et al.Journal of Virology|January 15, 2004
CD81 is required for hepatitis C virus glycoprotein-mediated viral infectionJie Zhang, Glenn Randall, Adrian Higginbottom, et al.British Journal of Pharmacology|February 28, 2002
Pharmacological characterization of the chemokine receptor, CCR5Anja Mueller, Nasir G Mahmoud, Marc C Goedecke, et al.Virus Evolution|March 18, 2021
Estimating hepatitis B virus cccDNA persistence in chronic infectionKatrina A Lythgoe, Sheila F Lumley, Lorenzo Pellis, et al.Current Opinion in Virology|January 15, 2014
Entry of hepatitis B and C viruses - recent progress and future impactThomas F Baumert, Luke Meredith, Yi Ni, et al.Journal of Virology|October 26, 2007
Effect of cell polarization on hepatitis C virus entryChristopher J Mee, Joe Grove, Helen J Harris, et al.The Journal of General Virology|July 18, 2001
Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2Ania Owsianka, Reginald F Clayton, Lawrence D Loomis-Price, et al.Pageof 17